Trial intelligence / Profile preview

Vitamin D supplementation and androgen levels in hypogonadal men

2011-003575-11Phase 3Completed

Sponsor
Medical University of Graz, University Clinic for Internal Medicine
Start
Feb 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Hypoandrogenism (TD) and sex hormone disorder comparing Colecalciferol 20,000 IU weekly with Placebo (2 arms). Primary endpoint: Change in total testosterone. Started Feb 2013; status: completed.

02

Drugs

cholecalciferol
03

Conditions

Hypoandrogenism (TD)sex hormone disorder

Beyond the preview

Go deeper on 2011-003575-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-003575-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call